← Back to Patent Explorer
US4994237A Expired / Lapsed US ⏱️ 0.0 years remaining

Microwave preservation of bioprostheses

Assignee: Beth Israel Deaconess Medical Center
•
Filing: 1989-11-13
•
Granted: 1991-02-19
•
Expires: 2009-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method to preserve and sterilize biological tissues by exposing the tissue to microwave irradiation, thereby limiting tissue exposure to standard organic preservatives and retaining tissue pliability and other qualities that characterize natural, unpreserved tissue.

Inventors

  • 👤 Gary R. Login
  • 👤 Robert G. Johnson
  • 👤 Ann M. Dvorak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:11
CPC Classifications
A; A61; A61L; A61L2/00; A61L2/16; A01; A01N; A01N1/00; A01N1/10; A01N1/16; A01N1/168; A61L2/02; A61L2/08; A61L2/12; A61L2/18; A61L2103/00; A61L2103/05

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 211 words
A method to preserve and sterilize bioprostheses comprising the following steps: immersing a specimen of biologic tissue in a preserving solution at room temperature (20° C.) selected from a member of the group consisting of: (a) 0.9% sodium chloride; (b) 0.87% sodium chloride, 0.12% sodium phosphate dibasic, and 0.015% sodium phosphate monobasic, pH 7.3-7.6 (PBS); (c) 20 mM Tris(hydroxymethyl)aminomethane and 0.9% sodium chloride, pH 7.3-7.6 (TRIS); (d) 25 mM N-2-hydroxyethylpiperazine-N 1 -2-ethanesulfonic acid, pH 7.3-7.6 (HEPES); (e) 0.001-0.1% glutaraldehyde in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (f) a calcium chelating agent in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; and (g) a calcium chelating agent and 0.001-0.1% glutaraldehyde in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; exposing the immersed specimen to microwave irradiation until the final temperature of the solution is between 35° and 50° C.; and, storing the irradiated specimen in a cold sterile osmotically balanced solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS.
Claim 2
Independent Claim 211 words
A method to preserve and sterilize bioprostheses comprising the following steps: immersing a specimen of biologic tissue in a preserving solution at room temperature (20° C.) selected from a member of the group consisting of: (a) 0.9% sodium chloride; (b) 0.87% sodium chloride, 0.12% sodium phosphate dibasic, and 0.015% sodium phosphate monobasic, pH 7.3-7.6 (PBS); (c) 20 mM Tris(hydroxymethyl)aminomethane and 0.9% sodium chloride, pH 7.3-7.6 (TRIS); (d) 25 mM N-2-hydroxyethylpiperazine-N 1 -2-ethanesulfonic acid, pH 7.3-7.6 (HEPES); (e) 0.001-0.1% glutaraldehyde in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (f) a calcium chelating agent in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; and (g) a calcium chelating agent and 0.001-0.1% glutaraldehyde in a solution selected from a member of the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; exposing the immersed specimen to microwave irradiation until the final temperature of the solution is between 35° and 50° C.; and, storing the irradiated specimen in a cold sterile osmotically balanced solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS.
Claim 3
Dependent Claim 41 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said biologic tissue is immersed in the osmotically balanced preserving solution within fifteen minutes after it is harvested from a donor animal and exposed to microwave irradiation.
Claim 4
Dependent Claim 24 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said preserving solution is osmotically balanced to said biologic tissue.
Claim 5
Dependent Claim 48 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said preserving solution is 1-100 mM of the calcium chelating agent ethylinediamenetetraacetic acid (EDTA) in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS.
Claim 6
Dependent Claim 48 words
The method to preserve and sterilize as set forth in claim 1 wherein said preserving solution is 1-100 mM of the calcium chelating agent EDTA and 0.001-0.1% glutaraldyde in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES and (4) TRIS.
Claim 7
Dependent Claim 43 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said biologic tissue is irradiated in a microwave oven for between one and fifty seconds until the solution reaches a temperature in the range of 35° to 50° C.
Claim 8
Dependent Claim 27 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said cold sterile osmotically balanced storage solution has a temperature of 4° C.
Claim 9
Dependent Claim 28 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said cold sterile osmotically balanced storage solution further comprises an inhibitor of microbial growth.
Claim 10
Dependent Claim 32 words
The method to preserve and sterilize bioprostheses as set forth in claim 8 wherein said inhibitor of microbial growth is selected from the group consisting of 0.02% sodium azide and 0.02% thimerosal.
Claim 11
Dependent Claim 27 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said cold sterile osmotically balanced storage solution further comprises a calcium chelating agent.
Claim 12
Dependent Claim 22 words
The method to preserve and sterilize bioprostheses as set forth in claim 10 wherein said calcium chelating agent is 1-100 mM EDTA.
Claim 13
Dependent Claim 25 words
The method to preserve and sterilize bioprostheses as set forth in claim 1 wherein said cold sterile osmotically balanced storage solution further comprises 0.001-0.1% glutaraldehyde.
Claim 14
Independent Claim 200 words
A method to preserve and sterilize bioprostheses comprising the following steps: harvesting a specimen of biologic tissue within fifteen minutes after sacrificing a donor animal; immersing said specimen of biologic tissue within fifteen minutes of harvesting in a room temperature an osmotically balanced solution selected from the group consisting of: (a) 0.9% sodium chloride; (b) PBS; (c) TRIS; (d) HEPES; (e) 0.001-0.1% glutaraldehyde in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (f) 1-100 mM EDTA in a solution selected from group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (g) 1-100 mM EDTA and 0.001-0.1% glutaraldehyde in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; exposing the immersed specimen to microwave irradiation within fifteen minutes of immersion in said preserving solution for 1-50 seconds until the temperature of the solution is between 35° and 50° C.; and, storing the irradiated specimen within thirty seconds of irradiation at 4° C. in a sterile osmotically balanced solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS.
Claim 15
Independent Claim 200 words
A method to preserve and sterilize bioprostheses comprising the following steps: harvesting a specimen of biologic tissue within fifteen minutes after sacrificing a donor animal; immersing said specimen of biologic tissue within fifteen minutes of harvesting in a room temperature an osmotically balanced solution selected from the group consisting of: (a) 0.9% sodium chloride; (b) PBS; (c) TRIS; (d) HEPES; (e) 0.001-0.1% glutaraldehyde in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (f) 1-100 mM EDTA in a solution selected from group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; (g) 1-100 mM EDTA and 0.001-0.1% glutaraldehyde in a solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS; exposing the immersed specimen to microwave irradiation within fifteen minutes of immersion in said preserving solution for 1-50 seconds until the temperature of the solution is between 35° and 50° C.; and, storing the irradiated specimen within thirty seconds of irradiation at 4° C. in a sterile osmotically balanced solution selected from the group consisting of (1) 0.9% sodium chloride, (2) PBS, (3) HEPES, and (4) TRIS.
Claim 16
Dependent Claim 44 words
The method to preserve and sterilize bioprostheses as set forth in claim 13 wherein said sterile osmotically balanced solution further comprises 1-100 mM EDTA, 0.001-0.1% glutaraldehyde, and an inhibitor of microbial growth selected from the group consisting of 0.02% sodium azide and 0.02% thimerosal.

References Cited (Backward Citations)

US1602489A Cited
US3479196A Cited
US3645849A Cited
US3743480A Cited
SU651815A1 Cited
US4351091A Cited
WO1984001894A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-02-18 1994-08-20 1995-02-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-02-18 1998-08-20 1999-02-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-02-18 2002-08-20 2003-02-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag